Mar 16, 2016 21:48 pm UTC| Business
WALTHAM, Mass., March 16, 2016 -- BeiGene, Ltd. (NASDAQ:BGNE) (“BeiGene”), a clinical-stage biopharmaceutical company focused on developing molecularly-targeted and immuno-oncological drugs for the treatment of cancer,...
Fox Factory Holding Corp. Announces Closing of Secondary Public Offering
Mar 16, 2016 21:35 pm UTC| Business
SCOTTS VALLEY, Calif., March 16, 2016 -- Fox Factory Holding Corp. (NASDAQ:FOXF) (the "Company") today announced the closing of the previously announced underwritten secondary public offering of 2,500,000 shares of its...
Galapagos doses first CF patient with G551D mutation in SAPHIRA 1 study
Mar 16, 2016 21:26 pm UTC| Business
MECHELEN, Belgium, March 16, 2016 -- Galapagos NV (Euronext NASDAQ: GLPG) announced today the first dosing in CF patients with the G551D mutation in the SAPHIRA 1 study. GLPG1837 is a candidate CFTR potentiator drug...
The Ensign Group Declares Quarterly Dividend of $0.04 Per Share
Mar 16, 2016 21:08 pm UTC| Business
MISSION VIEJO, Calif., March 16, 2016 -- The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care, assisted living...
Endeavour Mining files technical report for its Tabakoto Gold Mine
Mar 16, 2016 21:02 pm UTC| Business
View News Release in PDF Format GEORGE TOWN, Grand Cayman, March 16, 2016 -- Endeavour Mining Corporation (TSX:EDV)(OTCQX:EDVMF) has filed a NI 43-101 technical report entitled "Technical Report, Mineral Resource and...
Mar 16, 2016 21:00 pm UTC| Business
Two Late-Breaking Posters Featuring the Company’s Lead Drug Candidate, Selinexor (KPT-330), and Second Generation SINE Compound KPT-8602 Seventeen Additional Poster Presentations Highlighting Key Scientific Findings for...
Protea Announces 2015 Year End Results
Mar 16, 2016 21:00 pm UTC| Business
MORGANTOWN, W.Va., March 16, 2016 -- Protea Biosciences Group, Inc. (OTCQB:PRGB) (“Protea”) released its FY2015 results today, reporting total revenue of $2,003,286, an increase of 13% over FY2014 revenue of $1,768,312....